WHO IRISopen access
Opciones terapéuticas y COVID-19: orientaciones evolutivas, 10 de noviembre de 2023
covid-19, betacoronavirus, disease outbreaks, treatment outcome, antiviral agents, drug evaluation, hydroxychloroquine, lopinavir
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 356067
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.